VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1342966
                    [Title] => FDA panel backs avian flu vaccine for adults
                    [Summary] => 
A Food and Drug Administration advisory panel gave its unanimous support to vaccine designated for a national stockpile, where it would be reserved for use during an avian influenza pandemic or outbreak.

                    [DatePublished] => 2014-07-06 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 1340219
                    [Title] => Safety data needed for hepa B vaccine
                    [Summary] => 
Despite evidence of effectiveness and enthusiasm about its potential, more safety data in thousands of people are needed before two-dose hepatitis B vaccine can be approved for use in adults, according to the majority of Food and Drug Administration advisory panel.

                    [DatePublished] => 2014-06-29 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 56417
                    [Title] => GSK gets favorable FDA recommendation
                    [Summary] => 
            
                    [DatePublished] => 2008-04-17 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 199123
                    [Title] => New B strain slated for flu vaccine
                    [Summary] => The influenza vaccine to be given in the 2002-2003 flu season should be changed to include a component against the B/Hongkong/330/2001-like virus, the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee has recommended. 


                    [DatePublished] => 2003-03-16 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

FDA panel backs avian flu vaccine for adults

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | July 6, 2014 - 12:00am

A Food and Drug Administration advisory panel gave its unanimous support to vaccine designated for a national stockpile, where it would be reserved for use during an avian influenza pandemic or outbreak.

Opinion

Safety data needed for hepa B vaccine

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | June 29, 2014 - 12:00am

Despite evidence of effectiveness and enthusiasm about its potential, more safety data in thousands of people are needed before two-dose hepatitis B vaccine can be approved for use in adults, according to the majority...

Opinion

GSK gets favorable FDA recommendation

April 17, 2008 - 12:00am

Science and Environment

New B strain slated for flu vaccine

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | March 16, 2003 - 12:00am

The influenza vaccine to be given in the 2002-2003 flu season should be changed to include a component against the B/Hongkong/330/2001-like virus, the Food and Drug Administration’s Vaccines and Related Biological...

Opinion